NovoLog Mix 70/30
NDC 0169-2200, insulin aspart, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.
- Product NDC
- 0169-2200
- Status
- Listed
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA021172
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN ASPART100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-2200-11 | 00169220011 | 1 VIAL, GLASS in 1 CARTON (0169-2200-11) / 10 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1861fcee-7673-4afe-a206-08fa05c0add2
Use it
Look up 0169-2200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-2200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.